The present invention provides a compound of a formula (I): or a pharmaceutically acceptable salt thereof; a process for preparing such a compound; and to the use of such a compound in the treatment of an ENaC mediated disease state (such as asthma, CF or COPD).
申请公布号
AU2015233195(A1)
申请公布日期
2016.09.22
申请号
AU20150233195
申请日期
2015.03.17
申请人
AstraZeneca AB
发明人
Berglund, Susanne Elisabeth;Connolly, Stephen;Hemmerling, Martin;Hossain, Nafizal;Kristoffersson, Anna;Lundkvist, Johan Rune Michael;Nikitidis, Grigorios;Ripa, Lena Elisabeth;Shamovsky, Igor
